Eli Lilly committed $6 billion to a new plant in Alabama, establishing a drug-discovery lab with Abiomed strength.

The entities involved

• Eli Lilly and Company →

  American pharmaceutical company

  • Eli Lilly and Novo Nordisk are competing for market share in the weight loss drug sector.Sun 16:06
  • AbbVie, Eli Lilly, and Merck are broadening their therapeutic reach.Sun 10:21
• AbioMed →

  medical devices company based in Danvers, Massachusetts, USA

  Nothing else this week.

• Alabama →

  state of the United States of America

  • The administration is focusing on deep-red states as national economic concerns and high costs of living drive voter targeting efforts.Sun 23:15
  • Nucor is expanding its manufacturing operations in Decatur, Alabama, with support from state officials.Sat 18:13

Related events

• Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.Aug 5
• AbbVie and Eli Lilly are competing in the pharmaceutical market.Jun 18
• FDA endorsed broader use of a Lilly medicine, and Abogen furnished Novartis with RNA technology.Oct 15
• Eli Lilly and AstraZeneca are involved in drug development and market competition, with the FDA issuing approvals and legal actions involving both companies.Oct 7
• Ken Griffin made investment moves on October 18, 2026, buying shares of AbbVie and Abbott Laboratories, and boosting Eli Lilly shares.Oct 18